2 hours ago -
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
News Source
CNBC is the world leader in business news and real-time financial market coverage. Find fast, actionable information.
Anthropic to invest $100 million to train AI engineer talent
15 minutes ago
8.5K articles
2.8K articles
1.6K articles
34 articles
Comment